As of July 17, 2025, PW Medtech Group Ltd (1358.HK) reports a EV/EBITDA of 1.59.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing PW Medtech Group Ltd's EV/EBITDA to Peers
To better understand PW Medtech Group Ltd's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| PW Medtech Group Ltd (1358.HK) | 1.59 |
| Jiangsu Apon Medical Technology Co Ltd (300753.SZ) | 6878.69 |
| Beijing Bohui Innovation Biotechnology Group Co Ltd (300318.SZ) | 1358.94 |
| Shanghai Sanyou Medical Co Ltd (688085.SS) | 213.15 |
| Beijing Wandong Medical Technology Co Ltd (600055.SS) | 131.25 |
| Shanghai General Healthy Information and Technology Co Ltd (605186.SS) | 105.05 |
Compared to its competitors, PW Medtech Group Ltd's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.